Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04842266 · ClinicalTrials.gov registry record

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

A clinical trial of Trauma and Cancer Metastatic, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT04842266 is a study of Trauma and Cancer Metastatic that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 306-participant average among 56 other Trauma trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04842266, a study of Trauma and Cancer Metastatic, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The aim of this project is to assess the effectiveness of the IlluminOss pelvic implants in patients with pelvic metastatic disease presenting with pain, risk of pathologic fracture, non-displaced or minimally displaced pathologic fracture of the pelvis, and geriatric patients with pelvic fragility fractures. Results from this study will be used to confirm preliminary clinically and possibly statistically significant reductions in pain and improvements in function among these patients.

Interventions

  • DEVICE IlluminOss pelvic implant for oncologic indication
  • DEVICE IlluminOss pelvic implant for geriatric trauma indication

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-11-18
Est. Completion 2027-12

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04842266

The ClinicalTrials.gov registry entry for NCT04842266 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 306-participant average among 56 other Trauma trials with a reported enrollment target (67% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which IlluminOss pelvic implant for oncologic indication is the first listed.

NCT04842266 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04842266 about?

NCT04842266 is a clinical study titled "IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures". The aim of this project is to assess the effectiveness of the IlluminOss pelvic implants in patients with pelvic metastatic disease presenting with pain, risk of pathologic fracture, non-displaced or minimally displaced pathologic fracture of the pelvis, and geriatric patients with pelvic fragility ...

What is the current status of trial NCT04842266?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-11-18. Estimated completion is 2027-12.

What conditions does trial NCT04842266 study?

This clinical trial studies the following conditions: Trauma, Cancer Metastatic, Pathologic Fracture.

What interventions are being tested in trial NCT04842266?

The interventions under investigation include: IlluminOss pelvic implant for oncologic indication (DEVICE), IlluminOss pelvic implant for geriatric trauma indication (DEVICE).

Who is sponsoring clinical trial NCT04842266?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04842266 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.